involved in such research, ranging from community groups, through local councils, health authorities and statutory social welfare agencies, to academic groups.
Yet liaison between researchers in the field is currently not well developed. Not only are projects geographically dispersed, but backgrounds of researchers vary widely (psychologists and medics, staff of specialist drug agencies, police and probation services, sociologists and economists, local government workers and geographers, local residents and community workers, etc). It is in order to facilitate contacts and cross-fertilization between these research groups that we are setting up an Active Clearinghouse of Liaison between Regional and Local Drug Research Projects, which will consist of a newsletter, meetings and other activities.
I would be most grateful if any Journal readers who are involved in or planning local drug research projects would contact me, whereupon I shall place a description of their projects in an early issue of the newsletter and send them a copy.
NICHOLAS DORN

Book Reviews
The Harvey Lectures, Series 77, 1981-82 pp 232 US$35.95 ISBN 0-12-312077-2 New York: Academic Press (for the Harvey Society of New York) 1983 This volume represents the Harvey Society of New York Lectures of the 1981-82 session. The topics are: biosynthesis of plasma proteins (fibrinogen, prothrombin and a1-antitrypsin; the proteins of the red cell membrane and their relation to the cell skeleton, with implications for cell shape; mechanisms of adenylate cyclase activation and ADP-ribosylation, studied by cholera exotoxin; the macrophage and cell-mediated immunity; cell surface receptors-role in normal regulation and disease; the alpha interferons; and atherosclerosis-endothelial injury and smooth muscle proliferation.
The contributors are distinguished, the quality is high and the references are up to date (as at 1982). The volume is a valuable record for a library to hold. The general reader who dips into it will get many glimpses of modern molecular medicine. A symposium on nuclear cardiology occupying more than half of the volume may not meet with general approval. All the authors are specialists and write with authority, but only a few of them critically, and all either ignore or pay scant attention to the financial implications. Clinicians in the United Kingdom and United States for whom this publication is designed can no longer turn a blind eye to the cost of tests, the more so when they play little or no part in clinical decision-making and their information is available through less expensive investigations.
WALTER SOMERVILLE
Honorary Consultant Physician
The Middlesex Hospital, London
